These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6870301)

  • 1. [Analysis of electrophoretic mobility pattern of immunocompetent cells in the tumor-bearing host].
    Mori T; Yamada Y; Nakajima T; Iwaguchi T
    Gan To Kagaku Ryoho; 1983 May; 10(5):1342-53. PubMed ID: 6870301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Emergenec of low-mobility lymphocytes in the tumor-bearing status and its immunological significance].
    Iwaguchi T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):841-8. PubMed ID: 3485958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis of cancer using lymphocyte electrophoresis (2)].
    Mori T; Kohsaki G
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1675-82. PubMed ID: 6591858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pre- and postoperative reactivity of breast cancer patients to tumor associated antigens and HEP in the macrophage electrophoresis mobility (MEM) test].
    Ladusch M; Schäffner H; Ullmann L; Littmann M; Reimann S; Gindl P; Ambrosius H
    Arch Geschwulstforsch; 1982; 52(6):469-78. PubMed ID: 6186223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the macrophage electrophoretic mobility test and the leukocyte migration inhibition test in the detection of histocompatibility antigens on tumor cells.
    Bubeník J; Cochran AJ; Todd G; Malkovský M; Jandlová T; Suhajová E; Boubelík M
    Neoplasma; 1981; 28(2):185-93. PubMed ID: 7019742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the electrophoretic mobility of mouse lymphocytes, thymocytes, macrophages and tumour cells following immunisation.
    Hartveit F; Cater DB; Mehrishi JN
    Br J Exp Pathol; 1968 Dec; 49(6):634-47. PubMed ID: 5706992
    [No Abstract]   [Full Text] [Related]  

  • 7. Reactivity in neoplasia, preneoplasia, and pregnancy of lymphocytes against fetal extracts: cross-reactions between man and mouse.
    Pasternak G; Schlott B; Reinhöfer J; Gryschek G; von Broen B; Albrecht S
    J Natl Cancer Inst; 1982 Nov; 69(5):997-1004. PubMed ID: 6957663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of low-mobility T lymphocytes in cancer patients and its clinical significance.
    Nakajima T; Mori T; Iwaguchi T
    Int J Cancer; 1983 Jun; 31(6):681-6. PubMed ID: 6602776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of some immunological and biochemical changes of immunocompetent cells during tumor growth in rats.
    Koníková E; Hrivnáková A; Babusíková O
    Neoplasma; 1986; 33(5):583-93. PubMed ID: 3785465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reaction of inhibition of macrophage electrophoretic mobility in differential diagnosis of carcinomas].
    Miuller M; Irmsher Iu; Fisher R; Grosmann G
    Vopr Onkol; 1976; 22(12):43-50. PubMed ID: 1020256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graft-versus-leukemia reactivity involves cluster formation between superantigen-reactive donor T lymphocytes and host macrophages.
    Müerköster S; Wachowski O; Zerban H; Schirrmacher V; Umansky V; Rocha M
    Clin Cancer Res; 1998 Dec; 4(12):3095-106. PubMed ID: 9865926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
    Preece AW; Light PA
    Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of antitumor immunity of tumor-bearing mice with low-dose cyclophosphamide.
    Tzai TS; Lin JS; Chow NH
    J Surg Res; 1996 Oct; 65(2):139-44. PubMed ID: 8903460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophages and resistance of tumors 6. The effects of supernatants from cultures of normal and tumor cells on phagocytosis.
    Nelson M; Nelson DS
    J Reticuloendothel Soc; 1982 May; 31(5):433-50. PubMed ID: 7120229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage-mediated, antibody-dependent destruction of tumor cells in DBA/2 mice: in vitro identification of an in situ mechanism.
    Key M; Haskill S
    J Natl Cancer Inst; 1981 Jan; 66(1):103-10. PubMed ID: 7005500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process.
    Barbera-Guillem E; Nyhus JK; Wolford CC; Friece CR; Sampsel JW
    Cancer Res; 2002 Dec; 62(23):7042-9. PubMed ID: 12460925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.
    Field EJ; Caspary EA; Smith KS
    Br J Cancer Suppl; 1973 Aug; 1():208-14. PubMed ID: 4140728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-11-induced reduction of C/EBP transcription factor binding may contribute to the IL-12 downregulation in tumor-bearing mice.
    Torroella-Kouri M; Keith JC; Ivanova M; Lopez DM
    Int J Oncol; 2003 Feb; 22(2):439-48. PubMed ID: 12527946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo.
    Gabizon A; Leibovich SJ; Goldman R
    J Natl Cancer Inst; 1980 Nov; 65(5):913-20. PubMed ID: 6933261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.